Antiinterleukin-5 Antibody Prevents Airway Hyperresponsiveness in a Murine Model of Airway Sensitization

Eckard Hamelmann(National Jewish Health), Akihiro Oshiba(National Jewish Health), J Loader(National Jewish Health), Gary L. Larsen(National Jewish Health), G.J. Gleich(National Jewish Health), J Lee(National Jewish Health), Erwin W. Gelfand(National Jewish Health)
American Journal of Respiratory and Critical Care Medicine
March 1, 1997
Cited by 262

Abstract

Eosinophils play a central role in the inflammatory response associated with bronchial asthma. We studied the involvement of eosinophils in the development of airway hyperresponsiveness (AHR) in a mouse model of allergic airway sensitization. Sensitization of BALB/c mice to OVA via the airways induced allergen-specific T-cell responses, IgE production, immediate cutaneous hypersensitivity (ICH), and increased airway reactivity. Airway sensitization was associated with eosinophil infiltration of the airways and increased production of interleukin-5 (IL-5) in cultures of peribronchial lymph node cells. Treatment of OVA-challenged animals with anti-IL-5 antibody during the sensitization protocol completely abolished the infiltration of eosinophils into the lung tissue and prevented the development of AHR without affecting levels of allergen-specific IgE, cutaneous hypersensitivity and allergen-specific T cell responses. These findings demonstrate that infiltration of lung tissue by eosinophils, triggered by increased IL-5 production, is a major factor in the development of AHR in this mouse model of airway sensitization.


Related Papers

No related papers found

Powered by citation graph analysis